{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:16:30Z","timestamp":1785204990825,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to assess the profile of nasal microbiome and evaluate the effect of a specific nasal decolonization solution on the microbiome. We conducted a randomized, placebo-controlled, and parallel-group clinical study of 50 volunteers aged 18\u00a0years and older. The subjects were randomly assigned to receive a nasal antiseptic solution, containing povidone-iodine as the main ingredient, (n\u2009=\u200925) or a control solution (n\u2009=\u200925). Nasal swabs were obtained before application (baseline) and at 3 timepoints after application (5\u00a0min, 2\u00a0h, 24\u00a0h). Nasal swabs were subjected to next generation sequencing analysis and cultured in agar plates. At baseline, there were substantial associations between anaerobic species, <jats:italic>Corynebacterium<\/jats:italic> spp., <jats:italic>Staphylococcus<\/jats:italic> spp., and <jats:italic>Dolosigranulum<\/jats:italic> spp. Then, a high bioburden reduction was observed after the application of povidone-iodine (log<jats:sub>10<\/jats:sub> 3.68\u2009\u00b1\u20090.69 at 5\u00a0min; log<jats:sub>10<\/jats:sub> 3.57\u2009\u00b1\u20090.94 at 2\u00a0h; log<jats:sub>10<\/jats:sub> 1.17\u2009\u00b1\u20091.40 at 24\u00a0h), compared to the control. The top species affected by the treatment were <jats:italic>Cutibacterium acnes, Staphylococcus,<\/jats:italic> and <jats:italic>Corynebacterium<\/jats:italic> species. None of the subjects experienced any adverse effects, nor increases in mucociliary clearance time. Antiseptic solutions applied to the anterior nares can transiently and markedly reduce the bioburden of the nose. The registration number for this clinical trial is NCT05617729.<\/jats:p>","DOI":"10.1038\/s41598-023-46792-8","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T07:01:59Z","timestamp":1721458919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nasal microbiome and the effect of nasal decolonization with a novel povidone-iodine antiseptic solution: a prospective and randomized clinical trial"],"prefix":"10.1038","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct05617729","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Diana","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Chisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Citardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"key":"46792_CR1","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","volume":"379","author":"SS Magill","year":"2018","unstructured":"Magill, S. S. et al. Changes in prevalence of health care-associated infections in U.S. Hospitals. N. Engl. J. Med. 379, 1732\u20131744 (2018).","journal-title":"N. Engl. J. Med."},{"key":"46792_CR2","unstructured":"CDC. HAI Data. (2019). at https:\/\/www.cdc.gov\/hai\/data\/index.html"},{"key":"46792_CR3","unstructured":"World Health Organization. in (eds Ducel, G., Fabry, J. & Nicolle, L.) (World Health Organization, 2002). https:\/\/apps.who.int\/iris\/handle\/10665\/67350"},{"key":"46792_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.ajic.2019.07.003","volume":"47","author":"KA Reagan","year":"2019","unstructured":"Reagan, K. A. et al. You get back what you give: Decreased hospital infections with improvement in CHG bathing, a mathematical modeling and cost analysis. Am. J. Infect. Control 47, 1471\u20131473 (2019).","journal-title":"Am. J. Infect. Control"},{"key":"46792_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa0808939","volume":"362","author":"LGM Bode","year":"2010","unstructured":"Bode, L. G. M. et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 362, 9\u201317 (2010).","journal-title":"N. Engl. J. Med."},{"key":"46792_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nrmicro.2017.104","volume":"15","author":"B Krismer","year":"2017","unstructured":"Krismer, B., Weidenmaier, C., Zipperer, A. & Peschel, A. The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat. Rev. Microbiol. 15, 675\u2013687 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"46792_CR7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1171700","volume":"324","author":"EA Grice","year":"2009","unstructured":"Grice, E. A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190\u20131192 (2009).","journal-title":"Science"},{"key":"46792_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(48)92088-1","volume":"1","author":"B Moss","year":"1948","unstructured":"Moss, B. & Squire, J. R. Nose and skin carriage of Staphylococcus aureus in patients receiving penicillin. Lancet (London, England) 1, 320\u2013325 (1948).","journal-title":"Lancet (London, England)"},{"key":"46792_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jhin.2011.04.028","volume":"79","author":"JA Otter","year":"2011","unstructured":"Otter, J. A. & French, G. L. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J. Hosp. Infect. 79, 189\u2013193 (2011).","journal-title":"J. Hosp. Infect."},{"key":"46792_CR10","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","volume":"37","author":"LM Weiner","year":"2016","unstructured":"Weiner, L. M. et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the national healthcare safety network at the Centers for disease control and prevention, 2011\u20132014. Infect. Control Hosp. Epidemiol. 37, 1288\u20131301 (2016).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"46792_CR11","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1111\/1462-2920.12891","volume":"18","author":"U Kaspar","year":"2016","unstructured":"Kaspar, U. et al. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ. Microbiol. 18, 2130\u20132142 (2016).","journal-title":"Environ. Microbiol."},{"key":"46792_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.chom.2013.11.005","volume":"14","author":"M Yan","year":"2013","unstructured":"Yan, M. et al. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe 14, 631\u2013640 (2013).","journal-title":"Cell Host Microbe"},{"key":"46792_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrmicro2537","volume":"9","author":"EA Grice","year":"2011","unstructured":"Grice, E. A. & Segre, J. A. The skin microbiome. Nat. Rev. Microbiol. 9, 244\u2013253 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"46792_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","volume":"152","author":"SI Berr\u00edos-Torres","year":"2017","unstructured":"Berr\u00edos-Torres, S. I. et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 152, 784\u2013791 (2017).","journal-title":"JAMA Surg."},{"key":"46792_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(18)32593-5","volume":"393","author":"SS Huang","year":"2019","unstructured":"Huang, S. S. et al. Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): A cluster-randomised trial. Lancet (London, England) 393, 1205\u20131215 (2019).","journal-title":"Lancet (London, England)"},{"key":"46792_CR16","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1128\/AAC.04624-14","volume":"59","author":"MJ Anderson","year":"2015","unstructured":"Anderson, M. J. et al. Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares. Antimicrob. Agents Chemother. 59, 2765\u20132773 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"46792_CR17","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s11999-015-4191-3","volume":"473","author":"MD Baratz","year":"2015","unstructured":"Baratz, M. D., Hallmark, R., Odum, S. M. & Springer, B. D. Twenty percent of patients may remain colonized with methicillin-resistant staphylococcus aureus despite a decolonization protocol in patients undergoing elective total joint arthroplasty. Clin. Orthop. Relat. Res. 473, 2283\u20132290 (2015).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"46792_CR18","doi-asserted-by":"publisher","first-page":"e0252004","DOI":"10.1371\/journal.pone.0252004","volume":"16","author":"M-C Roghmann","year":"2021","unstructured":"Roghmann, M.-C. et al. Effect of mupirocin for Staphylococcus aureus decolonization on the microbiome of the nose and throat in community and nursing home dwelling adults. PLoS One 16, e0252004 (2021).","journal-title":"PLoS One"},{"key":"46792_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1128\/AAC.25.4.422","volume":"25","author":"TP McAnally","year":"1984","unstructured":"McAnally, T. P., Lewis, M. R. & Brown, D. R. Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob. Agents Chemother. 25, 422\u2013426 (1984).","journal-title":"Antimicrob. Agents Chemother."},{"key":"46792_CR20","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jid.2016.01.016","volume":"136","author":"JS Meisel","year":"2016","unstructured":"Meisel, J. S. et al. Skin microbiome surveys are strongly influenced by experimental design. J. Invest. Dermatol. 136, 947\u2013956 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"46792_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/msphere.01202-20","volume":"6","author":"A-S Isabel","year":"2021","unstructured":"Isabel, A.-S. et al. Primer, pipelines, parameters: Issues in 16S rRNA gene sequencing. mSphere 6, 10\u20131128. https:\/\/doi.org\/10.1128\/msphere.01202-20 (2021).","journal-title":"mSphere"},{"key":"46792_CR22","doi-asserted-by":"publisher","first-page":"e47075","DOI":"10.1371\/journal.pone.0047075","volume":"7","author":"S Conlan","year":"2012","unstructured":"Conlan, S., Kong, H. H. & Segre, J. A. Species-level analysis of DNA sequence data from the NIH human microbiome project. PLoS One 7, e47075 (2012).","journal-title":"PLoS One"},{"key":"46792_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2023.03.084","author":"D Fern\u00e1ndez-Rodr\u00edguez","year":"2023","unstructured":"Fern\u00e1ndez-Rodr\u00edguez, D. et al. Human knee has a distinct microbiome: Implications for periprosthetic joint infection. J. Arthroplasty https:\/\/doi.org\/10.1016\/j.arth.2023.03.084 (2023).","journal-title":"J. Arthroplasty"},{"key":"46792_CR24","doi-asserted-by":"crossref","unstructured":"Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214 (2012).","DOI":"10.1038\/nature11234"},{"key":"46792_CR25","doi-asserted-by":"publisher","first-page":"e1400216","DOI":"10.1126\/sciadv.1400216","volume":"1","author":"CM Liu","year":"2022","unstructured":"Liu, C. M. et al. Staphylococcus aureus and the ecology of the nasal microbiome. Sci. Adv. 1, e1400216 (2022).","journal-title":"Sci. Adv."},{"key":"46792_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fcimb.2020.00137","volume":"10","author":"A Bassiouni","year":"2020","unstructured":"Bassiouni, A. et al. Microbiotyping the sinonasal microbiome. Front. Cell. Infect. Microbiol. 10, 137 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"46792_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSphere.01015-20","volume":"6","author":"AL Cole","year":"2021","unstructured":"Cole, A. L. et al. Identification of nasal gammaproteobacteria with potent activity against Staphylococcus aureus: Novel insights into the \u2018noncarrier\u2019 state. mSphere 6, 10\u20131128 (2021).","journal-title":"mSphere"},{"key":"46792_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/metabo12060489","volume":"12","author":"LA Adolf","year":"2022","unstructured":"Adolf, L. A. & Heilbronner, S. Nutritional interactions between bacterial species colonising the human nasal cavity: Current knowledge and future prospects. Metabolites 12, 489 (2022).","journal-title":"Metabolites"},{"key":"46792_CR29","first-page":"7.2","volume":"7","author":"L Claudia","year":"2019","unstructured":"Claudia, L., Andreas, P. & Bernhard, K. Staphylococcus aureus colonization of the human nose and interaction with other microbiome members. Microbiol. Spectr. 7, 7.2 (2019).","journal-title":"Microbiol. Spectr."},{"key":"46792_CR30","first-page":"657","volume":"99","author":"MY Ali","year":"1965","unstructured":"Ali, M. Y. Histology of the human nasopharyngeal mucosa. J. Anat. 99, 657\u2013672 (1965).","journal-title":"J. Anat."},{"key":"46792_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0732-8893(01)00328-5","volume":"42","author":"LM Deshpande","year":"2002","unstructured":"Deshpande, L. M., Fix, A. M., Pfaller, M. A. & Jones, R. N. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): Correlations of results from disk diffusion, Etest and reference dilution methods. Diagn. Microbiol. Infect. Dis. 42, 283\u2013290 (2002).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"46792_CR32","first-page":"207","volume":"10","author":"MA Menberu","year":"2021","unstructured":"Menberu, M. A. et al. Corynebacterium accolens has antimicrobial activity against Staphylococcus aureus and methicillin-resistant S. aureus pathogens isolated from the sinonasal niche of chronic rhinosinusitis patients. Pathogens (Basel, Switzerland) 10, 207 (2021).","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"46792_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/jhin.1999.0680","volume":"44","author":"Y Uehara","year":"2000","unstructured":"Uehara, Y. et al. Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp.. J. Hosp. Infect. 44, 127\u2013133 (2000).","journal-title":"J. Hosp. Infect."},{"key":"46792_CR34","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1513\/AnnalsATS.201806-439AW","volume":"15","author":"KH Benam","year":"2018","unstructured":"Benam, K. H., Vladar, E. K., Janssen, W. J. & Evans, C. M. Mucociliary defense: Emerging cellular, molecular, and animal models. Ann. Am. Thorac. Soc. 15, S210\u2013S215 (2018).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"46792_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/cpf.12085","volume":"34","author":"M Munkholm","year":"2014","unstructured":"Munkholm, M. & Mortensen, J. Mucociliary clearance: Pathophysiological aspects. Clin. Physiol. Funct. Imaging 34, 171\u2013177 (2014).","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"46792_CR36","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s10096-012-1641-7","volume":"31","author":"WMJ Dunne","year":"2012","unstructured":"Dunne, W. M. J., Westblade, L. F. & Ford, B. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol. 31, 1719\u20131726 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"46792_CR37","doi-asserted-by":"publisher","first-page":"215265672091160","DOI":"10.1177\/2152656720911605","volume":"11","author":"S Dimitri-Pinheiro","year":"2020","unstructured":"Dimitri-Pinheiro, S., Soares, R. & Barata, P. The microbiome of the nose-friend or foe?. Allergy Rhinol. (Providence) 11, 2152656720911605 (2020).","journal-title":"Allergy Rhinol. (Providence)"},{"key":"46792_CR38","doi-asserted-by":"publisher","first-page":"769775","DOI":"10.3389\/fimmu.2021.769775","volume":"12","author":"Z-B Wu","year":"2021","unstructured":"Wu, Z.-B. et al. Dynamic interaction between mucosal immunity and microbiota drives nose and pharynx homeostasis of common carp (Cyprinus carpio) after SVCV infection. Front. Immunol. 12, 769775 (2021).","journal-title":"Front. Immunol."},{"key":"46792_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s42003-021-01796-w","volume":"4","author":"R Xu","year":"2021","unstructured":"Xu, R. et al. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun. Biol. 4, 240 (2021).","journal-title":"Commun. Biol."},{"key":"46792_CR40","doi-asserted-by":"publisher","first-page":"xtac020","DOI":"10.1093\/femsmc\/xtac020","volume":"3","author":"M Flynn","year":"2022","unstructured":"Flynn, M. et al. Interactions of the bacteriome, virome, and immune system in the nose. FEMS Microb. 3, xtac020 (2022).","journal-title":"FEMS Microb."},{"key":"46792_CR41","doi-asserted-by":"publisher","first-page":"23749","DOI":"10.1038\/s41598-021-02505-7","volume":"11","author":"K Goswami","year":"2021","unstructured":"Goswami, K. et al. Comparative meta-omics for identifying pathogens associated with prosthetic joint infection. Sci. Rep. 11, 23749 (2021).","journal-title":"Sci. Rep."},{"key":"46792_CR42","doi-asserted-by":"publisher","first-page":"e1008511","DOI":"10.1371\/journal.ppat.1008511","volume":"16","author":"CD Tipton","year":"2020","unstructured":"Tipton, C. D. et al. Patient genetics is linked to chronic wound microbiome composition and healing. PLoS Pathog. 16, e1008511 (2020).","journal-title":"PLoS Pathog."},{"key":"46792_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/00039896.1974.10666589","volume":"29","author":"I Andersen","year":"1974","unstructured":"Andersen, I., Camner, P., Jensen, P. L., Philipson, K. & Proctor, D. F. A comparison of nasal and tracheobronchial clearance. Arch. Environ. Health 29, 290\u2013293 (1974).","journal-title":"Arch. Environ. Health"},{"key":"46792_CR44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/thx.36.9.654","volume":"36","author":"J Rutland","year":"1981","unstructured":"Rutland, J. & Cole, P. J. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax 36, 654\u2013658 (1981).","journal-title":"Thorax"},{"key":"46792_CR45","unstructured":"OHara, R. B., Simpson, G., Solymos, P., Stevens, M. H. H. & Wagner, H. vegan: Community Ecology PackageR package version 1.17\u20138. (2011)."},{"key":"46792_CR46","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8, e61217 (2013).","journal-title":"PLoS One"},{"key":"46792_CR47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar, R. C. UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996\u2013998 (2013).","journal-title":"Nat. Methods"},{"key":"46792_CR48","unstructured":"Martinez Arbizu, P. pairwiseAdonis: Pairwise multilevel comparison using adonis. R Package version 0.4 (2020)."},{"key":"46792_CR49","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","volume":"11","author":"H Lin","year":"2020","unstructured":"Lin, H. & Peddada, S. Das. Analysis of compositions of microbiomes with bias correction. Nat. Commun. 11, 3514 (2020).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46792-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T07:03:44Z","timestamp":1721459024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46792-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["46792"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46792-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EC reports personal fees from Biolumen Inc., Cardinal Health Inc, ICMI LLC, MicrogenDx Inc., Probiotical SPA, personal fees and stocks from Parvizi Surgical Innovation LLC, stocks from Povinez LLC, CIRO LLC, and Surgiwipe LLC. JP reports personal fees and stock option from Corentec, personal fees from Data Trace, personal fees from Elsevier, personal fees from Jaypee Publishers, personal fees from SLACK Incorporated, personal fees from Wolters Kluwer, personal fees from Becton Dickensen, personal fees and non-financial support from Zimmer Biomet, personal fees from Ethicon, personal fees from Tenor, personal fees from KCI\/3M (Acelity), personal fees from MicroGenDx, personal fees from Jointstem, personal fees from Becton Dickenson, personal fees from Cardinal Health, stock option from Parvizi Surgical Innovation and Subsidiaries, stock option from Hip Innovation Technology, stock option from Alphaeon\/Strathsby Crown, stock option from Elute, stock option from Ceribell, stock option from Acumed, stock option from PRN-Veterinary, stock option from Illuminus, stock option from Intellijoint, stock option from Osteal, stock option from Nanooxygenic, stock option from Sonata, stock option from Molecular Surface Technologies, stock option from Peptilogic, non-financial support from NIH, non-financial support from OREF, non-financial support from 3M, non-financial support from Aesculap, non-financial support from AO Spine, non-financial support from Biomet, non-financial support from Cempra, non-financial support from DePuy, non-financial support from Integra, non-financial support from Lima, non-financial support from Myoscience, non-financial support from NDRI, non-financial support from Novartis, non-financial support from Pfizer, non-financial support from Rotation Medical, non-financial support from Simplify Medical, non-financial support from Smith & Nephew, non-financial support from Stelkast, non-financial support from Stryker Orthopedics, non-financial support from Synthes, non-financial support from TissueGene, non-financial support from Tornier, non-financial support from Orthospace,  outside the submitted work. All other authors declare no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16739"}}